MYD88 mutation is an oncogenic event strongly associated with ABC-DLBCL and Waldenstrom macroglobulinemia, the recurrent L265P mutation of MYD88 accounts for the majority of this association (63,64). Here, MYD88 is linked to Waldenstrom macroglobulinemia.